AGIO

Agios Pharmaceuticals Inc

• Simply Wall St·19h ago

  Is Agios Pharmaceuticals (AGIO) Undervalued On Hopes For A Mitapivat FDA Decision?

• Simply Wall St·4d ago

  How Investors May Respond To Agios Pharmaceuticals (AGIO) Sickle Cell FDA Review

• The Motley Fool·6d ago

  4 High-Risk Stocks Built for Big Returns

• TipRanks·10/09 01:47

  Agios Pharma (AGIO) Gets a Hold from RBC Capital

• Simply Wall St·10/08 10:27

  Agios Pharmaceuticals (AGIO) Screens As Undervalued, Can Its Rare Disease Pipeline Justify The Gap?

• Dow Jones·10/07 15:14

  Agios Pharmaceuticals Price Target Cut to $37.00/Share From $39.00 by Truist Securities

• Dow Jones·10/07 15:14

  Agios Pharmaceuticals Is Maintained at Buy by Truist Securities

• Benzinga·10/07 15:04

  Truist Securities Maintains Buy on Agios Pharmaceuticals, Lowers Price Target to $37

• TipRanks·10/07 13:07

  Agios Pharmaceuticals price target lowered to $37 from $39 at Truist

• TipRanks·10/06 10:40

  Analysts Offer Insights on Healthcare Companies: Agios Pharma (AGIO), Korro Bio (KRRO) and HeartBeam (BEAT)

• Simply Wall St·09/24 18:34

  Is Agios Pharmaceuticals (AGIO) Undervalued On Its PYRUKYND Expansion Story?

• Dow Jones·09/21 17:50

  Agios Pharmaceuticals Price Target Raised to $50.00/Share From $46.00 by B of A Securities

• Dow Jones·09/21 17:50

  Agios Pharmaceuticals Is Maintained at Buy by B of A Securities

• Benzinga·09/21 17:40

  B of A Securities Maintains Buy on Agios Pharmaceuticals, Raises Price Target to $50

• TipRanks·09/21 10:40

  Agios Pharmaceuticals price target raised to $50 from $46 at BofA